Researchers are examining the potential of CRISPR-Cas technology in treating breast cancer, exploring its advantages and limitations. The technology is being investigated as part of a broader effort to develop innovative strategies for cancer management, including precision medicine and targeted therapy. Various approaches, including tumor models and biomarkers, are being studied to improve cancer diagnosis, prognosis, and treatment.